Agf Investments LLC Ligand Pharmaceuticals Inc Transaction History

Agf Investments LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$96.94 - $113.59 $3,295 - $3,862	-34 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$86.25 - $120.16 $2,932 - $4,085	-34 Reduced 50.0%	34 $3,000
Q1 2019 May 13, 2019	BUY	$105.93 - $142.47 $7,203 - $9,687	68 New	68 $9,000
Q4 2018 Feb 08, 2019	SELL	$128.36 - $272.13 $17,200 - $36,465	-134 Closed	0 $0
Q3 2018 Nov 09, 2018	SELL	$211.18 - $274.49 $18,161 - $23,606	-86 Reduced 39.09%	134 $37,000
Q3 2018 Nov 07, 2018	SELL	$211.18 - $274.49 $9,925 - $12,901	-47 Reduced 17.6%	220 $25,000
Q2 2018 Aug 13, 2018	BUY	$150.77 - $207.98 $3,618 - $4,991	24 Added 9.88%	267 $57,000
Q1 2018 May 04, 2018	SELL	$138.63 - $182.62 $4,990 - $6,574	-36 Reduced 12.9%	243 $38,000
Q4 2017 Feb 07, 2018	BUY	$128.36 - $147.04 $35,812 - $41,024	279	279 $39,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $2.01B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Agf Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Agf Investments LLC with notifications on news.